Madrigal Pharmaceuticals, Inc. (MDGL)
425.79
-5.91
(-1.37%)
USD |
NASDAQ |
Oct 30, 10:29
Madrigal Pharmaceuticals Total Return Level : 431.70 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 431.70 |
| October 28, 2026 | 431.00 |
| October 27, 2026 | 440.33 |
| October 26, 2026 | 437.74 |
| October 23, 2026 | 434.24 |
| October 22, 2026 | 453.34 |
| October 21, 2026 | 457.96 |
| October 20, 2026 | 467.54 |
| October 19, 2026 | 447.09 |
| October 16, 2026 | 449.74 |
| October 15, 2026 | 459.81 |
| October 14, 2026 | 460.01 |
| October 13, 2026 | 452.12 |
| October 12, 2026 | 467.16 |
| October 09, 2026 | 471.75 |
| October 08, 2026 | 476.91 |
| October 07, 2026 | 487.72 |
| October 06, 2026 | 496.45 |
| October 05, 2026 | 493.62 |
| October 02, 2026 | 499.40 |
| October 01, 2026 | 499.71 |
| September 30, 2026 | 503.96 |
| September 29, 2026 | 509.44 |
| September 28, 2026 | 517.04 |
| September 25, 2026 | 516.56 |
| Date | Value |
|---|---|
| September 24, 2026 | 513.21 |
| September 23, 2026 | 513.02 |
| September 22, 2026 | 518.83 |
| September 21, 2026 | 521.96 |
| September 18, 2026 | 531.52 |
| September 17, 2026 | 534.40 |
| September 16, 2026 | 529.09 |
| September 15, 2026 | 523.26 |
| September 14, 2026 | 540.06 |
| September 11, 2026 | 534.49 |
| September 10, 2026 | 533.12 |
| September 09, 2026 | 546.66 |
| September 08, 2026 | 534.16 |
| September 04, 2026 | 541.08 |
| September 03, 2026 | 542.61 |
| September 02, 2026 | 546.93 |
| September 01, 2026 | 538.71 |
| August 31, 2026 | 540.03 |
| August 28, 2026 | 533.76 |
| August 27, 2026 | 543.69 |
| August 26, 2026 | 538.88 |
| August 25, 2026 | 512.16 |
| August 24, 2026 | 511.97 |
| August 21, 2026 | 516.74 |
| August 20, 2026 | 519.09 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 174.00 |
| Cytokinetics, Inc. | 63.31 |
| Insmed, Inc. | 111.59 |
| United Therapeutics Corp. | 593.54 |
| Karyopharm Therapeutics, Inc. | 0.8798 |